However, this method identifies BA.1 but rarely BA.2 based on the deletions in the viral S gene (Majumdar and Sarkar 2022; UKHSA 2022) and therefore may have led to reduced detection of BA.2, potentially favouring the emergence and spread of BA.2 viruses. The gene discussed is CFB; the disease is breast angiosarcoma.